W A Marijt

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. pmc Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
    W A Erik Marijt
    Department of Hematology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands
    Proc Natl Acad Sci U S A 100:2742-7. 2003
  2. ncbi request reprint Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
    Elisabeth H Slager
    Department of Hematology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Blood 107:4954-60. 2006
  3. ncbi request reprint Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
    Cornelis A M van Bergen
    Laboratory of Experimental Hematology, Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
    Blood 109:4089-96. 2007
  4. doi request reprint Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag')
    Peter A von dem Borne
    Department of Hematology C2 R, Leiden University Medical Center, Leiden, The Netherlands
    Curr Opin Oncol 21:S27-9. 2009

Collaborators

Detail Information

Publications4

  1. pmc Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
    W A Erik Marijt
    Department of Hematology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands
    Proc Natl Acad Sci U S A 100:2742-7. 2003
    ..This finding implies that in vitro generated HA-1- and HA-2-specific cytotoxic T lymphocytes could be used as adoptive immunotherapy to treat hematological malignancies relapsing after alloSCT...
  2. ncbi request reprint Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
    Elisabeth H Slager
    Department of Hematology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Blood 107:4954-60. 2006
    ..Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors...
  3. ncbi request reprint Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
    Cornelis A M van Bergen
    Laboratory of Experimental Hematology, Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
    Blood 109:4089-96. 2007
    ..In conclusion, the novel mHag LB-ADIR-1F may be a suitable target for cellular immunotherapy when applied under controlled circumstances...
  4. doi request reprint Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag')
    Peter A von dem Borne
    Department of Hematology C2 R, Leiden University Medical Center, Leiden, The Netherlands
    Curr Opin Oncol 21:S27-9. 2009
    ..AlloSCT with RIC and alemtuzumab-induced T-cell depletion offers a suitable platform for the investigation of novel cellular immunotherapy...